Errate: Nasal Mucociliary Clearance and Its Relationship With Disease Severity in Patients With Multiple Sclerosis

In the published version of Figure 2, the bars representing the Ocrelizumab and Fingolimod treatment groups were inadvertently interchanged. The data presented in Table 2 and described in the Results section are correct. The corrected Figure 2 is provided to replace the originally published figure. Reference: Caner Baydar, Abdulaziz Yalınkılıç, Yaser Said Çetin. Nasal Mucociliary Clearance and Its Relationship With Disease Severity in Patients With Multiple Sclerosis. Med Sci Monit. 2026; 32:e952850. DOI: 10.12659/MSM.952850.